ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients
February 25, 2021Genome & Company today announced having entered into a research collaboration for the discovery of innovative cancer therapies in the expanding antibody-drug conjugates (ADC) class. -
Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer
January 15, 2020Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical activit
Pharma Sources Insight January 2025
